ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OM vs NRXS // RETURN ON INVESTED CAPITAL (ROIC)

Outset Medical Inc. (NASDAQ) VS. Neuraxis Inc. (NYSE) • 15-METRIC TALLY: OM 4 — NRXS 3
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: OM
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OM VS. NRXS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OM NRXS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 39.10% 84.20% -45.10 NRXS /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -28.00% -35.00% +7.00 OM /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -6.82% — TIE /fcf-yield <GO>
Operating Margin -55.80% -60.00% +4.20 OM /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 5.10% 32.90% -27.80 NRXS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 1.88 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 5/9 +1.00 OM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.8 48.0 +3.80 OM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $78.8M $94.8M -$16.1M NRXS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OM REV NRXS REV OM GROSS % NRXS GROSS % OM FCF NRXS FCF
FY 2025 $119.5M $3.6M 39.1% 84.2% -$47.1M -$6.5M
FY 2024 $113.7M $2.7M 33.9% 86.5% -$117.2M -$6.1M
FY 2023 $130.4M $2.5M — — -$131.4M -$6.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OM // BETA —
NRXS // BETA —